Pregnancy diabetes: A comparison of diagnostic protocols based on point-of-care, routine and optimized laboratory conditions

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Van Den Berg, Sjoerd A A ^a   De Groot, Monique J M ^b   Salden, Lorenzo P W ^a   Draad, Patrick J G J ^a   Dijkstra, Ineke M ^c   Lunshof, Simone ^a   Van Thiel, Sjoerd W ^a   Boonen, Kristel J M ^a   Thelen, Marc H M ^a  

^a AMPHIA HOSPITAL   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c Dept of Clinical Chemistry   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE BLOOD LEVEL;

ANALYSIS; COMPARATIVE STUDY; DIABETES, GESTATIONAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; POINT OF CARE SYSTEM; PREGNANCY; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; POINT-OF-CARE SYSTEMS; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 84946735659     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16302     Document Type: Article

References (28)

1. B. E. Metzger et al. "Hyperglycemia and adverse pregnancy outcomes," N. Engl. J. Med. 358(19), 1991 (2008).
2. B. S. Buckley et al. "Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review," Diabet. Med. 29(7), 844 (2012).
3. A. Rebel, M. A. Rice & B. G. Fahy "Accuracy of point-of-care glucose measurements," J. Diabetes Sci. Technol. 6(2), 396 (2012).
4. E. Rush, N. Crook & D. Simmons "Point-of-care testing as a tool for screening for diabetes and pre-diabetes," Diabet. Med. 25(9), 1070 (2008).
5. J. V. Marley et al. "Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia," Med. J. Aust. 186(10), 500 (2007).
6. Lovrencic M. Vucic et al. "Validation of Point-of-Care Glucose Testing for Diagnosis of Type 2 Diabetes," Int. J. Endocrinol. 2013, 206309 (2013).
7. D. D. Martin et al. "Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community," Med. J. Aust. 182(10), 524 (2005).
8. E. Cengiz & W. V. Tamborlane "A tale of two compartments: interstitial versus blood glucose monitoring," Diabetes Technol. Ther. 11 Suppl 1, S11-S16 (2009).
9. R. Haeckel, R. Raber & W. Wosniok "Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge," Clin. Chem. Lab Med. 44(12), 1462 (2006).
10. D. B. Sacks et al. "Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus," Diabetes Care 34(6), 1419 (2011).
11. A. Y. Chan, R. Swaminathan & C. S. Cockram "Effectiveness of sodium fluoride as a preservative of glucose in blood," Clin. Chem. 35(2), 315 (1989).
12. M. Weissman & B. Klein "Evaluation of glucose determinations in untreated serum samples," Clin. Chem. 4(5), 420 (1958).
13. J. B. Field & H. E. Williams "Artifactual hypoglycemia associated with leukemia," N. Engl. J. Med. 265, 946 (1961).
14. L. Fernandez et al. "A comparison of glucose concentration in paired specimens collected in serum separator and fluoride/potassium oxalate blood collection tubes under survey 'field' conditions," Clin. Biochem. 46(4-5), 285 (2013).
15. J. Qin et al. "Fluoride inhibition of enolase: crystal structure and thermodynamics," Biochemistry 45(3), 793 (2006).
16. S. A. van den Berg et al. "It takes acid, rather than ice, to freeze glucose," Sci. Rep. 5, 8875 (2015).
17. S. A. van den Berg, M. H. Thelen & K. J. Boonen "Inventarisation of the (pre)analytical aspects of the glucose determination in Dutch laboratories: time for harmonization," Ned Tijdschr Klin Chem Labgeneesk 40(1), 69 (2015).
18. A. Basu et al. "Time lag of glucose from intravascular to interstitial compartment in humans," Diabetes 62(12), 4083 (2013).
19. A. Basu et al. "Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes," J. Diabetes Sci. Technol. 9(1), 63 (2015).
20. J. N. Roe & B. R. Smoller "Bloodless glucose measurements," Crit Rev. Ther. Drug Carrier Syst. 15(3), 199 (1998).
21. M. Fobker "Stability of glucose in plasma with different anticoagulants," Clin. Chem. Lab Med. 52(7), 1057 (2014).
22. S. P. Juraschek, M. W. Steffes & E. Selvin "Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose," Clin. Chem. 58(12), 1648 (2012).
23. S. P. Juraschek et al. "Alternative markers of hyperglycemia and risk of diabetes," Diabetes Care 35(11), 2265 (2012).
24. R. Unnikrishnan, R. M. Anjana & V. Mohan "Drugs affecting HbA1c levels," Indian J. Endocrinol. Metab 16(4), 528 (2012).
25. J. M. Rhea & R. Molinaro "Pathology consultation on HbA(1c) methods and interferences," Am. J. Clin. Pathol. 141(1), 5 (2014).
26. C. M. Zheng et al. "Glycated albumin in diabetic patients with chronic kidney disease," Clin. Chim. Acta 413(19-20), 1555 (2012).
27. M. Montagnana et al. "Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects," Clin. Chim. Acta 423, 1 (2013).
28. R. T. Jansen & R. J. Slingerland "SKML-Quality Mark for point-of-care test (POCT) glucose meters and glucose meters for homeuse," Clin. Chem Lab Med. 48(7), 1021 (2010).